Page 127 - Fertility in Women with Rheumatoid Arthritis Vruchtbaarheid van vrouwen met reumatoïde artritis

REFERENCES
1. Gotestam Skorpen, C., et al., The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis, 2016.
2. de Man, Y.A., et al., Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum, 2009. 60(11): p. 3196-206.
3. de Steenwinkel, F.D., et al., Rheumatoid arthritis during pregnancy and postnatal catch-up growth in the offspring. Arthritis Rheumatol, 2014. 66(7): p. 1705-11.
4. Willemze, A., et al., The influence of ACPA status and characteristics on the course of RA. Nat Rev Rheumatol, 2012. 8(3): p. 144-52.
5. Peart, E. and M.E. Clowse, Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol, 2014. 26(2): p. 118-23.
6. Gasparin, A.A., et al., Assessment of anti-Mullerian hormone levels in premenopausal patients with systemic lupus erythematosus. Lupus, 2016. 25(3): p. 227-32.
7. Lawrenz, B., et al., Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone. Lupus, 2011. 20(11): p. 1193-7.
8. Haga, H.J., et al., Reproduction and gynaecological manifestations in women with primary Sjogren’s syndrome: a case-control study. Scand J Rheumatol, 2005. 34(1): p. 45-8.
9. Lehrer, S., et al., Gynecologic manifestations of Sjogren’s syndrome. Am J Obstet Gynecol, 1994. 170(3): p. 835-7.
10. Karakus, S., et al., Evaluation of ovarian reserve using anti-mullerian hormone and antral follicle count in Sjogren’s syndrome: Preliminary study. J Obstet Gynaecol Res, 2017. 43(2): p. 303-307.
11. Aletaha, D., et al., 2010 Rheumatoid arthritis classi cation criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Arthritis Rheum, 2010. 62(9): p. 2569-81.
12. Smolen, J.S., et al., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Annals of the rheumatic diseases, 2010. 69(6): p. 964-75.
13. Dekel, N., et al., The Role of Inflammation for a Successful Implantation. Am J Reprod Immunol, 2014.
8
General discussion
125